Abstract
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2)
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have